vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $57.6M, roughly 1.0× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 41.4%). Phathom Pharmaceuticals, Inc. produced more free cash flow last quarter ($-167.0M vs $-695.9M).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

CIFR vs PHAT — Head-to-Head

Bigger by revenue
CIFR
CIFR
1.0× larger
CIFR
$59.7M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+52.7% gap
PHAT
94.1%
41.4%
CIFR
More free cash flow
PHAT
PHAT
$528.9M more FCF
PHAT
$-167.0M
$-695.9M
CIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIFR
CIFR
PHAT
PHAT
Revenue
$59.7M
$57.6M
Net Profit
$-734.2M
Gross Margin
59.4%
86.7%
Operating Margin
-503.4%
Net Margin
-1229.6%
Revenue YoY
41.4%
94.1%
Net Profit YoY
-4293.1%
71.6%
EPS (diluted)
$-1.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
PHAT
PHAT
Q4 25
$59.7M
$57.6M
Q3 25
$71.7M
$49.5M
Q2 25
$43.6M
$39.5M
Q1 25
$49.0M
$28.5M
Q4 24
$42.2M
$29.7M
Q3 24
$24.1M
$16.4M
Q2 24
$36.8M
$7.3M
Q1 24
$48.1M
Net Profit
CIFR
CIFR
PHAT
PHAT
Q4 25
$-734.2M
Q3 25
$-3.3M
$-30.0M
Q2 25
$-45.8M
$-75.8M
Q1 25
$-39.0M
$-94.3M
Q4 24
$17.5M
Q3 24
$-86.8M
$-85.6M
Q2 24
$-15.3M
$-91.4M
Q1 24
$39.9M
Gross Margin
CIFR
CIFR
PHAT
PHAT
Q4 25
59.4%
86.7%
Q3 25
62.7%
87.5%
Q2 25
64.8%
87.2%
Q1 25
69.6%
86.9%
Q4 24
56.9%
87.1%
Q3 24
37.5%
85.6%
Q2 24
61.2%
81.2%
Q1 24
69.2%
Operating Margin
CIFR
CIFR
PHAT
PHAT
Q4 25
-503.4%
Q3 25
-52.5%
-30.8%
Q2 25
-103.9%
-151.7%
Q1 25
-77.8%
-276.5%
Q4 24
40.5%
Q3 24
-379.2%
-433.0%
Q2 24
-43.9%
-1055.4%
Q1 24
97.2%
Net Margin
CIFR
CIFR
PHAT
PHAT
Q4 25
-1229.6%
Q3 25
-4.6%
-60.5%
Q2 25
-105.1%
-191.9%
Q1 25
-79.6%
-330.7%
Q4 24
41.5%
Q3 24
-359.9%
-523.3%
Q2 24
-41.5%
-1248.6%
Q1 24
82.9%
EPS (diluted)
CIFR
CIFR
PHAT
PHAT
Q4 25
$-1.91
Q3 25
$-0.01
$-0.41
Q2 25
$-0.12
$-1.05
Q1 25
$-0.11
$-1.31
Q4 24
$0.04
Q3 24
$-0.26
$-1.32
Q2 24
$-0.05
$-1.56
Q1 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$628.3M
$130.0M
Total DebtLower is stronger
$2.7B
$209.1M
Stockholders' EquityBook value
$805.5M
$-438.2M
Total Assets
$4.3B
$259.1M
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
PHAT
PHAT
Q4 25
$628.3M
$130.0M
Q3 25
$1.2B
$135.2M
Q2 25
$62.7M
$149.6M
Q1 25
$23.2M
$212.3M
Q4 24
$5.6M
$297.3M
Q3 24
$25.3M
$334.7M
Q2 24
$122.6M
$276.2M
Q1 24
$88.7M
Total Debt
CIFR
CIFR
PHAT
PHAT
Q4 25
$2.7B
$209.1M
Q3 25
$1.0B
$207.1M
Q2 25
$167.1M
$205.1M
Q1 25
$203.2M
Q4 24
$0
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
CIFR
CIFR
PHAT
PHAT
Q4 25
$805.5M
$-438.2M
Q3 25
$783.2M
$-422.5M
Q2 25
$748.9M
$-405.8M
Q1 25
$734.8M
$-338.4M
Q4 24
$682.0M
$-253.6M
Q3 24
$672.0M
$-187.1M
Q2 24
$690.8M
$-233.8M
Q1 24
$600.9M
Total Assets
CIFR
CIFR
PHAT
PHAT
Q4 25
$4.3B
$259.1M
Q3 25
$2.8B
$240.3M
Q2 25
$1.0B
$250.2M
Q1 25
$913.8M
$294.2M
Q4 24
$855.4M
$378.3M
Q3 24
$775.4M
$387.0M
Q2 24
$775.6M
$319.4M
Q1 24
$677.1M
Debt / Equity
CIFR
CIFR
PHAT
PHAT
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
PHAT
PHAT
Operating Cash FlowLast quarter
$-207.9M
$-166.8M
Free Cash FlowOCF − Capex
$-695.9M
$-167.0M
FCF MarginFCF / Revenue
-1165.4%
-290.0%
Capex IntensityCapex / Revenue
817.1%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.1B
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
PHAT
PHAT
Q4 25
$-207.9M
$-166.8M
Q3 25
$-50.1M
$-14.1M
Q2 25
$-56.2M
$-62.7M
Q1 25
$-47.2M
$-84.9M
Q4 24
$-87.5M
$-266.8M
Q3 24
$-6.5M
$-63.6M
Q2 24
$-25.4M
$-70.7M
Q1 24
$-26.6M
Free Cash Flow
CIFR
CIFR
PHAT
PHAT
Q4 25
$-695.9M
$-167.0M
Q3 25
$-256.2M
$-14.1M
Q2 25
$-87.5M
$-62.8M
Q1 25
$-71.8M
$-84.9M
Q4 24
$-227.0M
$-266.9M
Q3 24
$-83.2M
$-63.6M
Q2 24
$-33.2M
$-70.8M
Q1 24
$-34.5M
FCF Margin
CIFR
CIFR
PHAT
PHAT
Q4 25
-1165.4%
-290.0%
Q3 25
-357.3%
-28.6%
Q2 25
-200.9%
-159.0%
Q1 25
-146.7%
-297.9%
Q4 24
-537.6%
-899.8%
Q3 24
-345.0%
-389.0%
Q2 24
-90.2%
-966.2%
Q1 24
-71.7%
Capex Intensity
CIFR
CIFR
PHAT
PHAT
Q4 25
817.1%
0.4%
Q3 25
287.5%
0.1%
Q2 25
71.8%
0.2%
Q1 25
50.2%
0.1%
Q4 24
330.4%
0.5%
Q3 24
317.8%
0.3%
Q2 24
21.4%
0.6%
Q1 24
16.4%
Cash Conversion
CIFR
CIFR
PHAT
PHAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-5.00×
Q3 24
Q2 24
Q1 24
-0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons